VRHD: Virtual Reality During Hemodialysis

Sponsor
Cardenal Herrera University (Other)
Overall Status
Completed
CT.gov ID
NCT03456414
Collaborator
Hospital de Manises (Other), Universitat Politècnica de València (Other)
40
1
2
5.7
7.1

Study Details

Study Description

Brief Summary

The main objective of this investigation is to assess if an intradialysis virtual reality exercise-based program results in an improvement in physical function and if it results in high adherence rates to exercise. The secondary aim is to assess the effect of intradialysis VR in physical activity level, health related quality of life and in cognitive function.

Condition or Disease Intervention/Treatment Phase
  • Other: Virtual reality exercise during hemodialysis
N/A

Detailed Description

Participants will be randomized into one of two groups. The first group will start with 12 weeks of virtual reality exercise during hemodialysis and will carry on with a control period of 12 weeks. The second group will start with a control period of 12 weeks (no exercise) and will carry on with a virtual reality exercise period of 12 weeks.

The virtual reality exercise will undertake up to 30 minutes of exercise. After warming up, participants will play to an adapted 'treasure hunt' game. Their legs movements will be the players projected into an individual tv that will give them feedback regarding their achievements. The aim of the game will be to achieve the higher possible score.They will move their legs to pick up coins and to avoid bombs. An adapted Kinect technology will be used for the game development. The exercise session will end-up with a cool-down period that will include simple lower limb stretching exercises.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
All participants will receive during hemodialysis the conditions 'virtual reality exercise' for 12 weeks and 'control period-no exercise' for 12 more weeksAll participants will receive during hemodialysis the conditions 'virtual reality exercise' for 12 weeks and 'control period-no exercise' for 12 more weeks
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
A team of assessors, different to the researchers implementing the exercise, will record all dependent variables
Primary Purpose:
Treatment
Official Title:
Virtual Reality Exercise During Hemodialysis
Actual Study Start Date :
Apr 11, 2018
Actual Primary Completion Date :
Sep 1, 2018
Actual Study Completion Date :
Sep 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual reality during hemodialysis

During 12 weeks subjects will exercise during hemodialysis. The intervention will be virtual reality exercise during hemodialysis.

Other: Virtual reality exercise during hemodialysis
Subjects will play a virtual reality game specially adapted for subjects undertaking hemodialysis treatment

No Intervention: Control period - no exercise

During 12 weeks subjects will not exercise during hemodialysis

Outcome Measures

Primary Outcome Measures

  1. Change from baseline gait speed at 12 weeks [Baseline, 12 weeks]

    Speed to cover 4 meters at normal speed

Secondary Outcome Measures

  1. Change from baseline sit to stand 10 at 12 weeks [Baseline, 12 weeks]

    Time to perform 10 sit to stand repetitions,

  2. Change from baseline sit to stand 60 at 12 weeks [Baseline, 12 weeks]

    Sit to stand repetitions performed in 60 seconds

  3. Change from baseline timed up and go at 12 weeks [Baseline, 12 weeks]

    Time to stand up, walk 3 meters, come back and sit down again

  4. Change from baseline short physical performance battery at 12 weeks [Baseline, 12 weeks]

    Score achieved at the battery that includes balance tests, sit to stand to sit 5 and and gait speed

  5. Change from baseline handgrip at 12 weeks [Baseline, 12 weeks]

    Bilateral handgrip strength

  6. Change from baseline one-leg standing test at 12 weeks [Baseline, 12 weeks]

    Time achieved while standing on one leg

  7. Change from baseline one-leg heel rise test at 12 weeks [Baseline, 12 weeks]

    Number of heel rise repetitions achieved

  8. Change from baseline 6 minutes walk test at 12 weeks [Baseline, 12 weeks]

    Number of meters walked in 6 minutes

  9. Change from baseline Physical activity level at 12 weeks [Baseline, 12 weeks]

    Physical activity questionnaires

  10. Change from baseline Health related quality of life at 12 weeks [Baseline, 12 weeks]

    Short Form 36 questionnaire to measure health-related quality of life

  11. Change from baseline Cognitive function at 12 weeks [Baseline, 12 weeks]

    Mini-mental State Examination questionnaire

  12. Adherence [12 weeks]

    Sessions performed/sessions offered

  13. Healthcare resources expenditure and costs [12 months before starting the exercise program- 12 months after the starting date]

    Total amount in euros spent on external consultations, laboratory tests, radiology tests, hospital pharmacy, emergency department healthcare provision, and hospitalisation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least 3 months in hemodialysis treatment

  • Clinically stable

Exclusion Criteria:
  • Recent cardiac events (less than 3 months)

  • Unable to exercise

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital de Manises Manises Valencia Spain 46940

Sponsors and Collaborators

  • Cardenal Herrera University
  • Hospital de Manises
  • Universitat Politècnica de València

Investigators

  • Principal Investigator: Eva SEGURA-ORTÍ, PhD, Universidad CEU Cardenal Herrera, UCH CEU

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Eva Segura Ortí, Professor, Cardenal Herrera University
ClinicalTrials.gov Identifier:
NCT03456414
Other Study ID Numbers:
  • 2017/0638
First Posted:
Mar 7, 2018
Last Update Posted:
Jul 17, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eva Segura Ortí, Professor, Cardenal Herrera University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 17, 2020